Variables | Patients (%) |
Age | |
median | 66 years |
range | 48-84 years |
Cardiovascular comorbidity | 0 (0%) |
Breast side | |
Left | 22 (55%) |
Right | 16 (40%) |
Bilateral | 2 (5%) |
Pathological T Stage | |
pT1 | 37 (92.5%) |
pT2 | 3 (7.5%) |
Pathological N Stage | |
pN0-N1mi | 34 (85%) |
pN1a | 1 (2.5%) |
pNx | 5 (12.5%) |
range | 1-5 |
DIBH | |
yes | 8 (20%) |
no: | 32 (80%) |
-poor compliance | 4 (12.5%) |
-right breast | 16 (50%) |
Adjuvant Endocrine Therapy | |
yes: | 25 (62.5%) |
-Tamoxifen | 3 (12%) |
-AI | 22 (88%) |
no | 15 (37.5%) |
BCCT score | |
excellent/good | 28 (70%) |
fair/poor | 12 (30%) |
Lorenzo Livi, MD
Florence, Tuscany